A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...
Please provide your email address to receive an email when new articles are posted on . Researchers randomly assigned 261 patients with chronic limb-threatening ischemia (CLTI) on a 2:1 basis to ...
SAN FRANCISCO -- The Esprit BTK drug-eluting resorbable scaffold proved safe and effective for patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal artery disease, the Life-BTK ...
LAS VEGAS, NV—At 2 years, a drug-eluting resorbable scaffold continues to show sustained patency and safety compared with conventional angioplasty alone in patients with below-the-knee (BTK) chronic ...
A drug-eluting resorbable scaffold continues to keep many patients with below-the-knee (BTK) chronic limb-threatening ischemia (CLTI) free from repeat procedures, even after most of the device’s ...
Please provide your email address to receive an email when new articles are posted on . An aragonite-based scaffold for chondral defects had better outcomes vs. microfracture. Women had the same or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results